Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Artificial hearts are being used to help patients with total heart failure live normal lives past their life expectancy time line, or to help patients survive until their transplant date either by replacing the heart completely or by replacing the ventricles. The device is surgically implanted in the chest in order to help in the functioning of a deteriorating heart. An artificial heart may also be used temporarily and is removed once the heart starts functioning normally. In cases where the damage is severe, the biological heart is completely replaced with the artificial heart. An artificial heart is powered by either compressed air or electricity.
The rise in the number of cardiac disorders along with an increase in the geriatric population is anticipated to drive the artificial heart market in the coming years. Improper lifestyle, leading to deteriorating cardiac condition is expected to offer growth opportunities during the forecast period for the manufacturers of artificial heart.
The global Artificial Heart market was valued at US$ 17 million in 2019 and is expected to reach US$ 48 million by the end of 2026, growing at a CAGR of 16.0% during 2021-2026.
This report focuses on Artificial Heart volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Artificial Heart market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Artificial Heart Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Ventricular Assist Device (VAD)
Total Artificial Heart
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
SynCardia Systems
BiVACOR
CARMAT
Abbott
Cleveland Heart
AbioMed
Jarvik Heart
MyLVAD
Cirtec Medical Systems
Thoratec Corporation
The rise in the number of cardiac disorders along with an increase in the geriatric population is anticipated to drive the artificial heart market in the coming years. Improper lifestyle, leading to deteriorating cardiac condition is expected to offer growth opportunities during the forecast period for the manufacturers of artificial heart.
The global Artificial Heart market was valued at US$ 17 million in 2019 and is expected to reach US$ 48 million by the end of 2026, growing at a CAGR of 16.0% during 2021-2026.
This report focuses on Artificial Heart volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Artificial Heart market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Artificial Heart Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Ventricular Assist Device (VAD)
Total Artificial Heart
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
SynCardia Systems
BiVACOR
CARMAT
Abbott
Cleveland Heart
AbioMed
Jarvik Heart
MyLVAD
Cirtec Medical Systems
Thoratec Corporation
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
